---
layout: default
title: Clinic-Oriented Feasibility of a Sensor-Fused Wearable for Upper-Limb Function
---

# Clinic-Oriented Feasibility of a Sensor-Fused Wearable for Upper-Limb Function

**arXiv**: [2510.22913v1](https://arxiv.org/abs/2510.22913) | [PDF](https://arxiv.org/pdf/2510.22913.pdf)

**ä½œè€…**: Thanyanee Srichaisak, Arissa Ieochai, Aueaphum Aueawattthanaphisut

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºä¼ æ„Ÿå™¨èžåˆå¯ç©¿æˆ´è®¾å¤‡ï¼Œç”¨äºŽæ”¹å–„ä¸Šè‚¢åŠŸèƒ½åº·å¤çš„éœ‡é¢¤å’Œæ´»åŠ¨èŒƒå›´ã€‚**

**å…³é”®è¯**: `ä¼ æ„Ÿå™¨èžåˆ` `ä¸Šè‚¢åº·å¤` `éœ‡é¢¤æ£€æµ‹` `è®¾å¤‡ç«¯æŽ¨ç†` `å®‰å…¨è¾…åŠ©ç­–ç•¥` `æŠ€æœ¯å¯è¡Œæ€§`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šä¸Šè‚¢æ— åŠ›å’Œéœ‡é¢¤é™åˆ¶æ—¥å¸¸ç”Ÿæ´»æ´»åŠ¨ï¼Œé™ä½Žå®¶åº­åº·å¤ä¾ä»Žæ€§ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šé›†æˆè¡¨é¢è‚Œç”µã€IMUå’Œå¼¯æ›²/åŠ›ä¼ æ„Ÿå™¨ï¼Œé‡‡ç”¨ä½Žå»¶è¿Ÿè®¾å¤‡ç«¯æŽ¨ç†å’Œå®‰å…¨è¾…åŠ©ç­–ç•¥ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šåœ¨å¥åº·æˆäººä¸­æµ‹è¯•ï¼Œéœ‡é¢¤æŒ‡æ•°é™ä½Žï¼Œæ´»åŠ¨èŒƒå›´å’Œé‡å¤æ¬¡æ•°å¢žåŠ ï¼Œæ— ä¸è‰¯äº‹ä»¶ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Background: Upper-limb weakness and tremor (4--12 Hz) limit activities of
> daily living (ADL) and reduce adherence to home rehabilitation. Objective: To
> assess technical feasibility and clinician-relevant signals of a sensor-fused
> wearable targeting the triceps brachii and extensor pollicis brevis. Methods: A
> lightweight node integrates surface EMG (1 kHz), IMU (100--200 Hz), and
> flex/force sensors with on-device INT8 inference (Tiny 1D-CNN/Transformer) and
> a safety-bounded assist policy (angle/torque/jerk limits; stall/time-out).
> Healthy adults (n = 12) performed three ADL-like tasks. Primary outcomes:
> Tremor Index (TI), range of motion (ROM), repetitions (Reps min$^{-1}$).
> Secondary: EMG median-frequency slope (fatigue trend), closed-loop latency,
> session completion, and device-related adverse events. Analyses used
> subject-level paired medians with BCa 95\% CIs; exact Wilcoxon $p$-values are
> reported in the Results. Results: Assistance was associated with lower tremor
> prominence and improved task throughput: TI decreased by $-0.092$ (95\% CI
> [$-0.102$, $-0.079$]), ROM increased by $+12.65\%$ (95\% CI [$+8.43$,
> $+13.89$]), and Reps rose by $+2.99$ min$^{-1}$ (95\% CI [$+2.61$, $+3.35$]).
> Median on-device latency was 8.7 ms at a 100 Hz loop rate; all sessions were
> completed with no device-related adverse events. Conclusions: Multimodal
> sensing with low-latency, safety-bounded assistance produced improved movement
> quality (TI $\downarrow$) and throughput (ROM, Reps $\uparrow$) in a pilot
> technical-feasibility setting, supporting progression to IRB-approved patient
> studies. Trial registration: Not applicable (pilot non-clinical).

